Epstein Secrets

ufman Fellowship to intern in venture capital. 18 Burt Christensen was the retired head of R&D at Merck PharmaceuticaLs. Whitesides and Roy Vagelos, Merck's former CEO, also served as company directors. 13 EFTA_R1_01521482 EFTA02444567 606-064 The Whitesides Lab Whitesides was unusual as a scien

0 Assistant Professor, National Center for Nanoscience. Beijing Kim, Enoch 27 6 Surface Logix Corporation Laibinis. P.E. 20 1 Professor of Chemical Engineering. Vanderbilt Love. John C. 22 0 Postdoctoral Fellow. Harvard Medical School Mammen, M. 16 0 Theravance Mrksich, M 22 6 Professor. Universi

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

es Arnold Nikesh Arora President, Corporate and Government Affairs Chairman and Chief Executive Officer Dick and Barbara Dickinson Professor of Chemical Engineering and Biochemistry Senior Vice-President and Chief Business Officer Ayman Asfari Group Chief Executive Tewodros Ashenafi Chairman and Chief Execu

) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and

nd a half years as an analyst at Cornerstone Research, a business consulting firm focused on financial and econometric analysis. He earned an M.S. in Chemical Engineering from Stanford University and a B.S. in Chemical Engineering from MIT, with a focus on applications of engineering to the life sciences. 12 CONTROL N